India, Aug. 5 -- Today's top biotech gainers include Attovia Therapeutics, which surged following its Nasdaq debut; American Well, after reporting a narrower loss; Perrigo, which swung back to profit; and UroGen Pharma, following strong second-quarter financial results, among others.
Read on.
ATTO Soars on Nasdaq Debut
Attovia Therapeutics Inc. (ATTO) was one of the top gainers on Wednesday, with shares soaring more than 28% after making its Nasdaq debut.
This clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases made its debut on the Nasdaq, pricing its shares at $17 each.
The company's lead drug candidate ATTO-1310 completed dosing in a Phase 1 clinical trial in healthy volun...